Swiss National Bank’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$556M Buy
1,580,353
+105,080
+7% +$37.5M 0.32% 47
2025
Q4
$483M Sell
1,475,273
-74,660
-5% -$23.7M 0.29% 51
2025
Q3
$437M Sell
1,549,933
-77,600
-5% -$22.5M 0.25% 62
2025
Q2
$454M Buy
1,627,533
+111,500
+7% +$31.6M 0.27% 57
2025
Q1
$472M Sell
1,516,033
-1,900
-0.1% -$561K 0.33% 45
2024
Q4
$396M Sell
1,517,933
-74,300
-5% -$22M 0.26% 59
2024
Q3
$513M Buy
1,592,233
+5,500
+0.3% +$1.8M 0.33% 50
2024
Q2
$496M Sell
1,586,733
-16,000
-1% -$4.7M 0.34% 45
2024
Q1
$456M Sell
1,602,733
-70,000
-4% -$20.5M 0.32% 51
2023
Q4
$482M Sell
1,672,733
-45,900
-3% -$12.5M 0.35% 46
2023
Q3
$462M Sell
1,718,633
-210,800
-11% -$52.6M 0.36% 45
2023
Q2
$428M Sell
1,929,433
-188,100
-9% -$43.6M 0.29% 62
2023
Q1
$512M Sell
2,117,533
-56,500
-3% -$13.9M 0.35% 51
2022
Q4
$571M Sell
2,174,033
-140,993
-6% -$37.8M 0.41% 45
2022
Q3
$522M Sell
2,315,026
-101,300
-4% -$24.6M 0.37% 47
2022
Q2
$588M Sell
2,416,326
-23,300
-1% -$5.71M 0.4% 47
2022
Q1
$590M Buy
2,439,626
+281,200
+13% +$64.6M 0.33% 53
2021
Q4
$486M Sell
2,158,426
-113,400
-5% -$23.9M 0.29% 64
2021
Q3
$483M Sell
2,271,826
-83,300
-4% -$19.2M 0.31% 63
2021
Q2
$574M Buy
2,355,126
+59,308
+3% +$14.6M 0.35% 55
2021
Q1
$571M Buy
2,295,818
+28,400
+1% +$6.78M 0.38% 49
2020
Q4
$521M Sell
2,267,418
-33,400
-1% -$7.7M 0.37% 52
2020
Q3
$585M Sell
2,300,818
-31,800
-1% -$7.88M 0.46% 42
2020
Q2
$550M Buy
2,332,618
+26,500
+1% +$6.05M 0.47% 40
2020
Q1
$468M Buy
2,306,118
+415,000
+22% +$90.6M 0.5% 38
2019
Q4
$456M Sell
1,891,118
-123,300
-6% -$27.2M 0.47% 34
2019
Q3
$390M Sell
2,014,418
-14,208
-0.7% -$2.73M 0.41% 42
2019
Q2
$374M Sell
2,028,626
-99,800
-5% -$17.9M 0.4% 48
2019
Q1
$404M Buy
2,128,426
+24,300
+1% +$4.64M 0.44% 45
2018
Q4
$410M Sell
2,104,126
-8,200
-0.4% -$1.6M 0.53% 33
2018
Q3
$438M Sell
2,112,326
-115,600
-5% -$22.8M 0.49% 36
2018
Q2
$411M Buy
2,227,926
+69,500
+3% +$12.3M 0.47% 38
2018
Q1
$368M Sell
2,158,426
-534,982
-20% -$98.2M 0.45% 40
2017
Q4
$468M Sell
2,693,408
-18,900
-0.7% -$3.34M 0.51% 36
2017
Q3
$506M Buy
2,712,308
+21,400
+0.8% +$3.79M 0.58% 34
2017
Q2
$463M Buy
2,690,908
+54,900
+2% +$8.93M 0.55% 33
2017
Q1
$432M Buy
2,636,008
+551,600
+26% +$91.7M 0.54% 32
2016
Q4
$305M Buy
2,084,408
+2,300
+0.1% +$346K 0.48% 33
2016
Q3
$347M Sell
2,082,108
-26,100
-1% -$4.41M 0.56% 31
2016
Q2
$321M Buy
2,108,208
+148,600
+8% +$23.1M 0.52% 33
2016
Q1
$282M Buy
1,959,608
+581,600
+42% +$86.4M 0.52% 34
2015
Q4
$224M Buy
1,378,008
+15,900
+1% +$2.5M 0.54% 33
2015
Q3
$188M Buy
1,362,108
+130,600
+11% +$20.6M 0.48% 37
2015
Q2
$189M Buy
1,231,508
+65,900
+6% +$10.6M 0.49% 33
2015
Q1
$186M Buy
1,165,608
+459,300
+65% +$72.3M 0.5% 33
2014
Q4
$113M Sell
706,308
-18,800
-3% -$2.93M 0.42% 49
2014
Q3
$102M Sell
725,108
-10,800
-1% -$1.41M 0.39% 54
2014
Q2
$87.1M Buy
735,908
+4,900
+0.7% +$567K 0.32% 64
2014
Q1
$90.2M Sell
731,008
-71,700
-9% -$8.7M 0.35% 59
2013
Q4
$91.6M Sell
802,708
-9,500
-1% -$1.08M 0.36% 62
2013
Q3
$90.9M Buy
812,208
+15,700
+2% +$1.7M 0.38% 57
2013
Q2
$78.6M Buy
+796,508
New +$82.7M 0.35% 59

Other funds holding AMGN

Swiss National Bank's AMGN Position: Q1 2026 in Review

Swiss National Bank increased its Amgen (AMGN) stake by 7.1% in Q1 2026, buying an estimated $37.5M and bringing the position to 1,580,353 shares worth $556M. The position accounts for 0.32% of the portfolio, ranked #47.

Swiss National Bank first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $590M in Q1 2022. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Swiss National Bank held 1,580,353 shares of Amgen worth $556M as of Q1 2026.
  • Swiss National Bank bought 105,080 Amgen shares in Q1 2026, an estimated $37.5M.
  • Amgen made up 0.32% of Swiss National Bank's portfolio in Q1 2026, its #47 holding.
  • Swiss National Bank first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Swiss National Bank's Amgen position peaked at $590M in Q1 2022.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.